News
Video News
Mining Videos
News
Coin
Video News
Mining Videos
Search
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
10 hours ago
Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus to potential seizure …
Read Entire Article
Homepage
News
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
Related
How China's BYD Is Beating Tesla As Musk Faces Challenges - ...
2 hours ago
The Great Unplugging: Bitcoin ATMs Face Steepest Drop Since ...
2 hours ago
DOGE Barks Again—Are Meme Coins Making a Comeback?
2 hours ago
Read the email Jack Dorsey sent when he cut 931 of Block’s s...
3 hours ago
Ripple Closes In On Legal Resolution With SEC, Will Recover ...
3 hours ago
Cotton Weaker on Tuesday
3 hours ago
Gamestop Unleashes Bitcoin Strategy—Can $4.8B Make GME a Cry...
3 hours ago
Bitcoin price has 75% chance of hitting new highs in 2025 — ...
3 hours ago
Popular
White House Crypto Czar Meets UAE Leader to Discuss Crypto a...
23 hours ago
Bitcoin, Ethereum, Dogecoin Match Stocks Rally As Trump Hint...
23 hours ago
Asian stocks rise on easing tariff worries; dollar perks up
23 hours ago
It’s Following The SAME Playbook… What Happens Next Will SHO...
23 hours ago
Giza Pyramid Cover-Up EXPOSED: Massive City, Hidden Tunnels ...
23 hours ago
Turkey Finance Czar Will Meet Investors to Ease Pressure on ...
21 hours ago